The Asia Pacific Ultrasound Transducer Market would witness market growth of 4.5% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 530.0 thousand units, showcasing a growth of 4.9% (2019-2022).
To conduct remote consultations with patients in remote or underserved locations, healthcare providers cannot function without ultrasound transducers. During these virtual appointments, patients can be guided by a local healthcare professional or even self-administer the ultrasound examination under remote supervision. The real-time imaging provided by ultrasound transducers allows physicians to visualize and assess various conditions, such as musculoskeletal injuries, obstetric complications, or abdominal pain, without needing an in-person visit.
Additionally, individuals with chronic illnesses that call for routine monitoring, such as heart disease, diabetes, or renal problems, benefit significantly from telemedicine platforms with ultrasound capabilities. Patients can use handheld ultrasound devices with transducers to perform routine scans at home, transmitting the data to their healthcare providers for continuous assessment and adjustment of treatment plans. Ultrasound transducers are crucial in point-of-care diagnostics in emergency departments and critical care units. Portable ultrasound machines with specialized transducers allow physicians to rapidly assess and diagnose life-threatening conditions, such as cardiac tamponade, pulmonary embolism, or trauma-related injuries. Immediate access to diagnostic information can expedite critical interventions and improve patient outcomes.
National Health Mission (NHM) is a comprehensive program to improve healthcare delivery across India. The Government of India estimates that the value of the hospital sector in India was $ 61.79 billion in FY17 and will increase to $ 132 billion by 2023. The National Digital Health Blueprint can generate an additional $200 billion economic value for India's healthcare sector over the next ten years. Owing to these factors, the regional market will grow rapidly in the upcoming years.
The China market dominated the Asia Pacific Ultrasound Transducer Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $412 million by 2030. The Japan market is registering a CAGR of 3.8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 5.1% during (2023 - 2030).
Based on Product Type, the market is segmented into Convex, Linear, Phased Array, Endocavitary, CW Doppler, and Others. Based on End Use, the market is segmented into Hospital, Clinic, Diagnostic Center, and ASCs. Based on Application, the market is segmented into General Imaging, Cardiovascular, Musculoskeletal, Vascular, OB/GYN, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Ultrasound Transducer Market is Predict to reach $4.9 Billion by 2030, at a CAGR of 3.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation), Hitachi, Ltd. (Hitachi Healthcare), SonoScape Medical Corp., Koninklijke Philips N.V., Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Esaote SpA
By Product Type (Volume, Thousand Units, USD Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Million, 2019-2030)
By Application (Volume, Thousand Units, USD Million, 2019-2030)
By Country (Volume, Thousand Units, USD Million, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
